Screener

Eligibility screening

Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors

Sponsored by EMD Serono Research & Development Institute, Inc.Study detailsClinicalTrials.gov

11 US sites in CA, DC, FL, SC +3

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.